a developer of drugs to improve the treatment of cancer
Industry Biotechnology
A.I.dvisor indicates that over the last year, ABUS has been loosely correlated with THRD. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ABUS jumps, then THRD could also see price increases.
Ticker / NAME | Correlation To ABUS | 1D Price Change % | ||
---|---|---|---|---|
ABUS | 100% | -2.54% | ||
THRD - ABUS | 39% Loosely correlated | +2.07% | ||
ROIV - ABUS | 38% Loosely correlated | +0.41% | ||
IDYA - ABUS | 37% Loosely correlated | +1.07% | ||
ERAS - ABUS | 36% Loosely correlated | +0.38% | ||
ALDX - ABUS | 36% Loosely correlated | +5.34% | ||
More |